These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 565937)

  • 1. [Value of treatment with immunosuppressive agents in chronic uveitis].
    Micşa M; Ciocan I; Zapolschi D
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1978; 22(1):63-6. PubMed ID: 565937
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of immunosuppressive drugs in uveitis.
    Carnahan MC; Goldstein DA
    Dev Ophthalmol; 1999; 31():132-59. PubMed ID: 10641205
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aspects of treatment with immunosuppressive agents in ophthalmology].
    Micşa MV; Weinberg J; Ciocan I; Zapolschi D; Popovici S
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1981; 25(3):233-5. PubMed ID: 6460300
    [No Abstract]   [Full Text] [Related]  

  • 4. Current and Emerging Pharmaceutical Therapies for Noninfectious Uveitis.
    Kodati S; Weng CY
    Int Ophthalmol Clin; 2019; 59(1):111-126. PubMed ID: 30585921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications for immunosuppressive treatment in kidney diseases of children].
    Wojnarowski M; Wyszyńska T
    Pediatr Pol; 1969 May; 44(5):525-30. PubMed ID: 4183009
    [No Abstract]   [Full Text] [Related]  

  • 6. Deflazacort in the treatment of uveitis: a comparative study versus prednisone.
    Cerqueti Piera M; Saccà Sergio C; Allegri P; Ciurlo G; Zingirian M; Buscaglia S; Ciprandi G
    Allergol Immunopathol (Madr); 1993; 21(3):107-10. PubMed ID: 8356936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of certolizumab pegol in chronic anterior uveitis associated to Crohn's disease and ankylosing spondylitis.
    Maiz Alonso O; Blanco Esteban AC; Egües Dubuc CA; Martinez Zabalegui D
    Reumatol Clin; 2015; 11(3):189-90. PubMed ID: 25555459
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of sight-threatening uveitis: new therapeutic options.
    Becker MD; Smith JR; Max R; Fiehn C
    Drugs; 2005; 65(4):497-519. PubMed ID: 15733012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Refractory anterior uveitis].
    Labalette P
    J Fr Ophtalmol; 2011 Feb; 34(2):122-6. PubMed ID: 21236513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of endogenous intraocular inflammation with azathioprine].
    Cerný M
    Cesk Oftalmol; 1971 May; 27(3):159-61. PubMed ID: 5104402
    [No Abstract]   [Full Text] [Related]  

  • 11. New therapies in development for the management of non-infectious uveitis: A review.
    Hassan M; Karkhur S; Bae JH; Halim MS; Ormaechea MS; Onghanseng N; Nguyen NV; Afridi R; Sepah YJ; Do DV; Nguyen QD
    Clin Exp Ophthalmol; 2019 Apr; 47(3):396-417. PubMed ID: 30938012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of electrophoresis of enzymes and other drugs in inflammatory diseases of the vascular tract].
    Katorgina OA; Fil'ts MA
    Oftalmol Zh; 1970; 25(7):489-94. PubMed ID: 5534356
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of immunosuppressive drug therapy in uveitis.
    Dunn JP
    Curr Opin Ophthalmol; 2004 Aug; 15(4):293-8. PubMed ID: 15232467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.
    Okada AA
    Ocul Immunol Inflamm; 2005; 13(5):335-51. PubMed ID: 16419419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs for the treatment of uveitis.
    Leung TG; Thorne JE
    Expert Opin Emerg Drugs; 2013 Dec; 18(4):513-21. PubMed ID: 24274613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of urokinases in some types of inflammation of the anterior segment].
    Diotti G; Gastaldi GM
    Minerva Oftalmol; 1969; 11(2):37-42. PubMed ID: 5407795
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.
    Yates WB; Vajdic CM; Na R; McCluskey PJ; Wakefield D
    Ophthalmology; 2015 Feb; 122(2):265-73. PubMed ID: 25312044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early clinical experience with leflunomide in uveitis.
    Roy M
    Can J Ophthalmol; 2007 Aug; 42(4):634. PubMed ID: 17641721
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunosuppressive agents in therapy].
    Ann Med Nav (Roma); 1968; 73(5):447-51. PubMed ID: 5743220
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunosuppressive treatment of skin diseases. I. Action of immunosuppressive drugs].
    Ruszczak Z
    Przegl Dermatol; 1974; 61(3):371-6. PubMed ID: 4152687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.